These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11490517)

  • 21. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
    Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systemic scleroderma : salivary immunoglobulins and the Gougerot-Sjögren syndrome].
    Fiessinger JN; Jarnet J; Capron L; Housset E
    Biomed Pharmacother; 1982 Jan; 36(1):51-4. PubMed ID: 7126773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo IgG deposits and reduced density of Langerhans cells in the surface epithelium of cervix uteri of patients with primary Sjögren's syndrome.
    Oxholm P; Manthorpe T; Manthorpe R; Oxholm A
    Scand J Rheumatol Suppl; 1986; 61():177-80. PubMed ID: 3473630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small-cell lymphoma and Sjögren's syndrome. Lymphoplasmacytic subvariant of small-cell lymphoma with IgA/kappa immunoglobulin surface markers.
    Askari AD; Laqui CC; Rassiga AL; Hogrefe WR; Laipply TC
    Arch Intern Med; 1985 May; 145(5):935-7. PubMed ID: 3922321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin deposits in labial mucosal epithelium of patients suspected of Sjögren's syndrome.
    Oxholm P; Manthorpe R; Oxholm A; Schiødt M
    Eur J Clin Invest; 1986 Feb; 16(1):91-6. PubMed ID: 3084278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
    Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
    J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe anemia and marrow plasmacytosis as presentation of Sjögren's syndrome.
    Tanvetyanon T; Leighton JC
    Am J Hematol; 2002 Mar; 69(3):233. PubMed ID: 11891816
    [No Abstract]   [Full Text] [Related]  

  • 28. [Variants in the course of Sjögren's disease].
    Vasil'ev VI; Kadagidze ZG; Simonova MV; Veskova TK; Iudina IuV
    Ter Arkh; 1982; 54(6):41-9. PubMed ID: 6981223
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevalence of antibodies against alpha-fodrin in Sjögren's syndrome: comparison of 2 sets of classification criteria.
    Witte T; Matthias T; Oppermann M; Helmke K; Peter HH; Schmidt RE; Tishler M
    J Rheumatol; 2003 Oct; 30(10):2157-9. PubMed ID: 14528510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosylation of immunoglobulin A influences its receptor binding.
    Basset C; Devauchelle V; Durand V; Jamin C; Pennec YL; Youinou P; Dueymes M
    Scand J Immunol; 1999 Dec; 50(6):572-9. PubMed ID: 10607305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sulfasalazine therapy for hypergammaglobulinemia in patients with Sjögren's syndrome].
    Imai F; Suzuki T; Ishibashi T; Ohno S; Tanaka M; Dohi Y
    Arerugi; 1994 Jan; 43(1):68-70. PubMed ID: 7908513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low sensitivity of anti-alpha-fodrin antibodies in patients with primary Sjögren's syndrome.
    Bizzaro N; Villalta D; Tonutti E
    J Rheumatol; 2004 Nov; 31(11):2310-1; author reply 2311. PubMed ID: 15517652
    [No Abstract]   [Full Text] [Related]  

  • 33. BAFF-induced changes in B cell antigen receptor-containing lipid rafts in Sjögren's syndrome.
    d'Arbonneau F; Pers JO; Devauchelle V; Pennec Y; Saraux A; Youinou P
    Arthritis Rheum; 2006 Jan; 54(1):115-26. PubMed ID: 16385503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG and IgM antiganglioside M1 antibodies in primary Sjogren's syndrome with and without peripheral neuropathy.
    Giordano N; Lucani B; Amendola A; Geraci S; Santacroce C; Gennari C; Hartini G; Nuti R
    Clin Rheumatol; 2003 Sep; 22(3):256-8. PubMed ID: 14505225
    [No Abstract]   [Full Text] [Related]  

  • 35. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
    Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
    Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome.
    van Woerkom JM; Kruize AA; Barendregt PJ; Kater L; Hené R; Bootsma H; Custers RJ; Jacobs JW; Bijlsma JW
    Rheumatology (Oxford); 2006 Apr; 45(4):470-7. PubMed ID: 16287920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Present status of primary Gougerot-Sjögren syndrome].
    Youinou P; Miossec P
    Nouv Presse Med; 1982 Nov; 11(47):3501-4. PubMed ID: 6218481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
    Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
    Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anti-alpha-fodrin antibodies: interest for the diagnosis of Sjögren' s syndromes].
    Dubucquoi S
    Rev Med Interne; 2005 Feb; 26(2):85-7. PubMed ID: 15710253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.